ImmunityBio Inc. Common Stock vs NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) — how do they compare? ImmunityBio Inc. Common Stock trades at $10.52 (market cap $10.51B), while NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.05 (market cap $66.98B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 6.4× ImmunityBio Inc. Common Stock's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays a 5.5% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 0 Days on average.
| IBRX | NWG | |
|---|---|---|
Market Cap | $10.51B | $66.98B |
Volume | 10,445,785 | 5,259,060 |
Sector | Health | Financials |
52-Week High | $11.55 | $19.42 |
52-Week Low | $1.98 | $13.89 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $140.55B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.
Read more on NWG →